Skip to main
BBU

BBU Stock Forecast & Price Target

BBU Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Brookfield Business Partners LP has demonstrated strong financial performance across its business segments, with notable contributions from Clarios, which reported an EBITDA of US$275 million, reflecting an 11% sequential increase and 8% year-over-year growth. Additionally, the company's Industrial Operations segment exhibited robust results, achieving an EBITDA of US$354 million, exceeding forecasts and marking a sequential increase of 12% and a year-over-year rise of 15.7%. Furthermore, the strong operating momentum in the residential mortgage insurance sector, highlighted by a 26% sequential rise in EBITDA from Sagen MI Canada, reinforces the company's overall positive outlook and growth potential.

Bears say

Brookfield Business Partners LP is facing significant financial challenges, as evidenced by a notable decline in EBITDA from its CDK Global segment, experiencing a decrease of approximately 10% quarter-over-quarter and 36% year-over-year. In addition, DexKo reported a substantial 33% drop in EBITDA, which reflects broader weaknesses within the company's revenue-generating segments. Furthermore, an anticipated compression of EV/EBITDA multiples across its key operational divisions due to underperformance of underlying investments adds to the negative outlook surrounding the company's financial health.

BBU has been analyzed by 3 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Brookfield Business Partners and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Brookfield Business Partners (BBU) Forecast

Analysts have given BBU a Buy based on their latest research and market trends.

According to 3 analysts, BBU has a Buy consensus rating as of Apr 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $42.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $42.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Brookfield Business Partners (BBU)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.